Global Technology – August 2016

When it comes to stopping pandemics, speed is of the essence.  

MIT engineers have developed a new type of easily customizable vaccine that can be manufactured in one week, allowing it to be rapidly deployed in response to disease outbreaks.  So far, they have designed vaccines against Ebola, H1N1 influenza, and Toxoplasma gondii (relative of the parasite that causes malaria), which were proven 100 percent effective in tests in mice.

The vaccine consists of strands of genetic material known as messenger RNA, which can be designe.....

This content is for BUSINESS BRIEFINGS members only.